282 related articles for article (PubMed ID: 38069284)
1. Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy.
Nemtsova MV; Kuznetsova EB; Bure IV
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069284
[TBL] [Abstract][Full Text] [Related]
2. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
[TBL] [Abstract][Full Text] [Related]
3. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal Instability in Gastric Cancer Biology.
Maleki SS; Röcken C
Neoplasia; 2017 May; 19(5):412-420. PubMed ID: 28431273
[TBL] [Abstract][Full Text] [Related]
5. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract][Full Text] [Related]
6. DNA Methylation and Genetic Aberrations in Gastric Cancer.
Usui G; Matsusaka K; Mano Y; Urabe M; Funata S; Fukayama M; Ushiku T; Kaneda A
Digestion; 2021; 102(1):25-32. PubMed ID: 33070127
[TBL] [Abstract][Full Text] [Related]
7. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtype switching in early-stage gastric cancers with multiple occurrences.
Takaoka S; Hirotsu Y; Ohyama H; Mochizuki H; Amemiya K; Oyama T; Ashizawa H; Yoshimura D; Nakagomi K; Hosoda K; Suzuki Y; Kojima Y; Omata M
J Gastroenterol; 2019 Aug; 54(8):674-686. PubMed ID: 30666417
[TBL] [Abstract][Full Text] [Related]
9. Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
Kohlruss M; Krenauer M; Grosser B; Pfarr N; Jesinghaus M; Slotta-Huspenina J; Novotny A; Hapfelmeier A; Schmidt T; Steiger K; Gaida MM; Reiche M; Bauer L; Ott K; Weichert W; Keller G
Br J Cancer; 2021 Dec; 125(12):1621-1631. PubMed ID: 34671125
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Sohn BH; Hwang JE; Jang HJ; Lee HS; Oh SC; Shim JJ; Lee KW; Kim EH; Yim SY; Lee SH; Cheong JH; Jeong W; Cho JY; Kim J; Chae J; Lee J; Kang WK; Kim S; Noh SH; Ajani JA; Lee JS
Clin Cancer Res; 2017 Aug; 23(15):4441-4449. PubMed ID: 28747339
[No Abstract] [Full Text] [Related]
11. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
[TBL] [Abstract][Full Text] [Related]
13. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Biesma HD; Soeratram TTD; Sikorska K; Caspers IA; van Essen HF; Egthuijsen JMP; Mookhoek A; van Laarhoven HWM; van Berge Henegouwen MI; Nordsmark M; van der Peet DL; Warmerdam FARM; Geenen MM; Loosveld OJL; Portielje JEA; Los M; Heideman DAM; Meershoek-Klein Kranenbarg E; Hartgrink HH; van Sandick J; Verheij M; van de Velde CJH; Cats A; Ylstra B; van Grieken NCT
Gastric Cancer; 2022 May; 25(3):640-651. PubMed ID: 35129727
[TBL] [Abstract][Full Text] [Related]
14. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
[TBL] [Abstract][Full Text] [Related]
15. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250
[TBL] [Abstract][Full Text] [Related]
16. Patterns of genomic instability in gastric cancer: clinical implications and perspectives.
Ottini L; Falchetti M; Lupi R; Rizzolo P; Agnese V; Colucci G; Bazan V; Russo A
Ann Oncol; 2006 Jun; 17 Suppl 7():vii97-102. PubMed ID: 16760303
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics of Epstein-Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization criteria.
Tanabe H; Mizukami Y; Takei H; Tamamura N; Omura Y; Kobayashi Y; Murakami Y; Kunogi T; Sasaki T; Takahashi K; Ando K; Ueno N; Kashima S; Yuzawa S; Hasegawa K; Sumi Y; Tanino M; Fujiya M; Okumura T
J Pathol Clin Res; 2021 Jul; 7(4):397-409. PubMed ID: 33750036
[TBL] [Abstract][Full Text] [Related]
18. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
[TBL] [Abstract][Full Text] [Related]
19. Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.
Derks S; de Klerk LK; Xu X; Fleitas T; Liu KX; Liu Y; Dietlein F; Margolis C; Chiaravalli AM; Da Silva AC; Ogino S; Akarca FG; Freeman GJ; Rodig SJ; Hornick JL; van Allen E; Li B; Liu SX; Thorsson V; Bass AJ
Ann Oncol; 2020 Aug; 31(8):1011-1020. PubMed ID: 32387455
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification of gastric cancer.
Röcken C
Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
